Inhibition of glyoxalase I: a possible transition-state analogue inhibitor approach to potential antineoplastic agents?
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D006367:HeLa Cells / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D007791:Lactoylglutathione Lyase / Q000037:antagonists & inhibitors*; D007939:Leukemia L1210 / Q000188:drug therapy; D008190:Lyases / Q000037:antagonists & inhibitors*; D051379:Mice; D011753:Pyrones / Q000494:pharmacology / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D011753:Pyrones; D008190:Lyases; D007791:Lactoylglutathione Lyase